SETBP1 OVEREXPRESSION IN CLASSICAL BCR/ABL1-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

被引：0
|
作者：
Albano, F. [1 ]
Anelli, L. [1 ]
Zagaria, A. [1 ]
Coccaro, N. [1 ]
Tota, G. [1 ]
Ricco, A. [1 ]
Casieri, P. [1 ]
Minervini, A. [1 ]
Impera, L. [1 ]
Minervini, C. Francesco [1 ]
Specchia, G. [1 ]
机构：
[1] Univ Bari, Hematol, DETO, Bari, Italy
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P258
引用
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [21] Increased mRNA expression for serotonin receptor 1B (HTR1B) is associated with thrombosis in BCR::ABL1-negative myeloproliferative neoplasms
    Gurban, Petruta
    Mambet, Cristina
    Botezatu, Anca
    Necula, Laura G.
    Matei, Lilia
    Neagu, Ana Iulia
    Pitica, Ioana Madalina
    Dragu, Laura Denisa
    Schulman, Alina Nastasie
    Ataman, Marius
    Nedeianu, Saviana
    Chivu-Economescu, Mihaela
    Bleotu, Coralia
    Anton, Gabriela
    Diaconu, Carmen Cristina
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (16)
  • [22] The Potential Role of CAL2 and EZH2 Immunohistochemical Stainings as Diagnostic and Prognostic Surrogate Markers in Classical BCR/ABL1-negative Myeloproliferative Neoplasms
    Ozogul, Ece
    Ozgeyik, Mufide Okay
    Ayhan, Arzu Saglam
    Malkan, Umit Yavuz
    Haznedaroglu, Ibrahim Celalettin
    Uner, Aysegul
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2023, 33 (04): : 248 - 257
  • [23] Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm
    Abbou, Norman
    Piazzola, Pauline
    Gabert, Jean
    Ernest, Vincent
    Arcani, Robin
    Couderc, Anne-Laure
    Tichadou, Antoine
    Roche, Pauline
    Farnault, Laure
    Colle, Julien
    Ouafik, L'houcine
    Morange, Pierre
    Costello, Regis
    Venton, Geoffroy
    CELLS, 2023, 12 (01)
  • [24] Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms
    Ding, Li
    Luo, Jie
    Zhang, Jing
    Wang, Ji
    Li, Zhao
    Huang, Juan
    Chai, Li
    Mu, Jiao
    Zhao, Beibei
    Zhong, Yi
    Zhang, Lin
    Liu, Lin
    ONCOLOGY LETTERS, 2022, 23 (01)
  • [25] Oxidant/Antioxidant Status in Patients with BCR-ABL1 Negative Myeloproliferative Neoplasms
    Benguella-Benmansour, Meriem
    Boucherit, Kebir
    Mesli, Naima
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2025, 41 (01) : 23 - 30
  • [26] Significance of Co-mutations in BCR-ABL1 Negative Myeloproliferative Neoplasms
    Zhou, Yi
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1054 - 1054
  • [27] Significance of Co-mutations in BCR-ABL1 Negative Myeloproliferative Neoplasms
    Zhou, Yi
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1054 - 1054
  • [28] Immunophenotypic Aberrancy on Basophils, a Biomarker for BCR-ABL1 Negative Myeloproliferative Neoplasms
    Chu, Andrew
    Kumar, Kirthi
    Monaghan, Sara A.
    Fuda, Franklin
    Chen, Weina
    LABORATORY INVESTIGATION, 2016, 96 : 340A - 340A
  • [29] Basophilia Predicts Poorer Outcomes in BCR-ABL1-Negative Myeloproliferative Neoplasms
    Yuen, Lisa
    Gogakos, Tasos
    Boiocchi, Leonardo
    Hobbs, Gabriela
    Hasserjian, Robert
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1048 - 1049
  • [30] The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms
    Vadeikiene, Roberta
    Jakstys, Baltramiejus
    Laukaitiene, Danguole
    Satkauskas, Saulius
    Juozaityte, Elona
    Ugenskiene, Rasa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
12345